Robert E. Molokie

4.2k total citations
152 papers, 2.7k citations indexed

About

Robert E. Molokie is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Robert E. Molokie has authored 152 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Genetics, 66 papers in Hematology and 54 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Robert E. Molokie's work include Hemoglobinopathies and Related Disorders (120 papers), Iron Metabolism and Disorders (51 papers) and Pharmacological Effects and Toxicity Studies (30 papers). Robert E. Molokie is often cited by papers focused on Hemoglobinopathies and Related Disorders (120 papers), Iron Metabolism and Disorders (51 papers) and Pharmacological Effects and Toxicity Studies (30 papers). Robert E. Molokie collaborates with scholars based in United States, Canada and Saudi Arabia. Robert E. Molokie's co-authors include Diana J. Wilkie, Marie L. Suarez, Joseph DeSimone, Yingwei Yao, Linda R. Bressler, Zaijie J. Wang, Louise Dorn, Donald Lavelle, Miriam O. Ezenwa and Victor R. Gordeuk and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Robert E. Molokie

145 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert E. Molokie United States 28 1.8k 1.2k 853 575 373 152 2.7k
Andrew Campbell United States 28 1.5k 0.8× 1.1k 1.0× 439 0.5× 480 0.8× 249 0.7× 88 2.2k
Deepika S. Darbari United States 26 1.8k 1.0× 1.3k 1.1× 697 0.8× 145 0.3× 210 0.6× 89 2.2k
Eugene P. Orringer United States 40 3.6k 2.0× 2.8k 2.4× 767 0.9× 650 1.1× 1.2k 3.1× 107 5.2k
Laura M. De Castro United States 23 1.7k 0.9× 1.3k 1.1× 480 0.6× 320 0.6× 320 0.9× 71 2.3k
Vincent Pradel France 24 373 0.2× 880 0.8× 185 0.2× 524 0.9× 151 0.4× 55 2.6k
Johanna M. W. Hazes Netherlands 29 288 0.2× 787 0.7× 90 0.1× 364 0.6× 106 0.3× 81 3.6k
Peter D. Cole United States 29 301 0.2× 261 0.2× 827 1.0× 408 0.7× 120 0.3× 135 2.6k
Gregoris Iconomou Greece 26 247 0.1× 466 0.4× 146 0.2× 314 0.5× 231 0.6× 62 2.5k
Luigi Bergamaschini Italy 29 938 0.5× 482 0.4× 42 0.0× 459 0.8× 437 1.2× 79 2.6k
Caroline Laverdière Canada 35 214 0.1× 511 0.4× 2.1k 2.4× 687 1.2× 263 0.7× 181 4.3k

Countries citing papers authored by Robert E. Molokie

Since Specialization
Citations

This map shows the geographic impact of Robert E. Molokie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Molokie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Molokie more than expected).

Fields of papers citing papers by Robert E. Molokie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Molokie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Molokie. The network helps show where Robert E. Molokie may publish in the future.

Co-authorship network of co-authors of Robert E. Molokie

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Molokie. A scholar is included among the top collaborators of Robert E. Molokie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Molokie. Robert E. Molokie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yao, Yingwei, et al.. (2024). Promise of Composite Pain Index as a single pain outcome for sickle cell disease across the lifespan. Pediatric Blood & Cancer. 71(6). e30958–e30958.
2.
Li, Hongjin, Judith M. Schlaeger, Crystal L. Patil, et al.. (2024). Barriers and Facilitators to Integrating Acupuncture into the U.S. Health Care System: A Scoping Review. Journal of Integrative and Complementary Medicine. 30(12). 1134–1146. 3 indexed citations
3.
Han, Jin, et al.. (2023). Iron Overload and Treatment Outcome in an Adult Sickle Cell Disease Cohort. Blood. 142(Supplement 1). 5331–5331.
4.
Molokie, Robert E., Santosh L. Saraf, Michael Pacini, et al.. (2023). Translating an HPFH-Mechanism into Oral Small Molecule Therapy for Beta-Hemoglobinopathies: Clinical Proof-of-Principle. Blood. 142(Supplement 1). 2524–2524.
5.
Horneman, Hart, Don Lavelle, Alan M. Diamond, et al.. (2023). Reticulocyte mitochondrial retention increases reactive oxygen species and oxygen consumption in mouse models of sickle cell disease and phlebotomy-induced anemia. Experimental Hematology. 122. 55–62. 13 indexed citations
6.
Han, Jin, Robert E. Molokie, Maria Armila Ruiz, et al.. (2023). Fruit and Vegetable Intake in Adults with Sickle Cell Disease. Blood. 142(Supplement 1). 5301–5301. 1 indexed citations
7.
Powell-Roach, Keesha, Yingwei Yao, Xueyuan Cao, et al.. (2023). Analysis of AVPR1A, thermal and pressure pain thresholds, and stress in sickle cell disease. SHILAP Revista de lepidopterología. 3. 1060245–1060245. 2 indexed citations
8.
Boyd, Andrew D., Larisa Burke, Ardith Z. Doorenbos, et al.. (2023). Monitoring and responding to signals of suicidal ideation in pragmatic clinical trials: Lessons from the GRACE trial for Chronic Sickle Cell Disease Pain. Contemporary Clinical Trials Communications. 36. 101218–101218. 1 indexed citations
9.
Han, Jin, Andrew Srisuwananukorn, Binal N. Shah, et al.. (2021). Effects of renin‐angiotensin blockade and APOL1 on kidney function in sickle cell disease. SHILAP Revista de lepidopterología. 2(3). 483–484. 5 indexed citations
10.
Han, Jin, Christopher Holden, Robert E. Molokie, et al.. (2020). Chronic opioid use can be reduced or discontinued after haematopoietic stem cell transplantation for sickle cell disease. British Journal of Haematology. 191(3). e70–e72. 4 indexed citations
11.
Myung, Ja Hye, Michael J. Poellmann, Alain Borgeat, et al.. (2019). Dendrimer-Based Platform for Effective Capture of Tumor Cells after TGFβ1-Induced Epithelial–Mesenchymal Transition. Analytical Chemistry. 91(13). 8374–8382. 10 indexed citations
12.
Ezenwa, Miriam O., Saunjoo L. Yoon, Roger B. Fillingim, et al.. (2019). A QST‐based Pain Phenotype in Adults With Sickle Cell Disease: Sensitivity and Specificity of Quality Descriptors. Pain Practice. 20(2). 168–178. 10 indexed citations
13.
Han, Jin, Xu Zhang, Santosh L. Saraf, et al.. (2018). Risk factors for vitamin D deficiency in sickle cell disease. British Journal of Haematology. 181(6). 828–835. 18 indexed citations
14.
Rivers, Angela, Kestis Vaitkus, Ramasamy Jagadeeswaran, et al.. (2018). Oral administration of the LSD1 inhibitor ORY-3001 increases fetal hemoglobin in sickle cell mice and baboons. Experimental Hematology. 67. 60–64.e2. 18 indexed citations
15.
Rivers, Angela, Kestis Vaitkus, Ramasamy Jagadeeswaran, et al.. (2017). Oral Administration of the LSD1 Inhibitor OG-S1335 Increases Fetal Hemoglobin in Humanized Transgenic Sickle Cell Disease Mice and in Baboons. Blood. 130. 356–356. 1 indexed citations
16.
He, Ying, Diana J. Wilkie, Rui Wang, et al.. (2016). PKCδ-targeted intervention relieves chronic pain in a murine sickle cell disease model. Journal of Clinical Investigation. 126(8). 3053–3057. 27 indexed citations
17.
Powell-Roach, Keesha, Robert E. Molokie, Zaijie Jim Wang, et al.. (2016). Validation of Painreportit Neuropathic Pain Scale in African American Adults with Sickle Cell Disease. Blood. 128(22). 3525–3525. 3 indexed citations
18.
He, Ying, et al.. (2014). Dopamine D3 Receptor Ser9Gly and Catechol-O-Methyltransferase Val158Met Polymorphisms and Acute Pain in Sickle Cell Disease. Anesthesia & Analgesia. 119(5). 1201–1207. 27 indexed citations
19.
Li, Jing, Kyungho Kim, Eunsil Hahm, et al.. (2014). Neutrophil AKT2 regulates heterotypic cell-cell interactions during vascular inflammation. Journal of Clinical Investigation. 124(4). 1483–1496. 52 indexed citations
20.
Haywood, Carlton, et al.. (2010). Sickle cell disease in the United States: Looking back and forward at 100 years of progress in management and survival. American Journal of Hematology. 85(5). 346–353. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Campbell Breakdown of academic impact, for papers by Deepika S. Darbari Breakdown of academic impact, for papers by Eugene P. Orringer Breakdown of academic impact, for papers by Laura M. De Castro Breakdown of academic impact, for papers by Vincent Pradel Breakdown of academic impact, for papers by Johanna M. W. Hazes Breakdown of academic impact, for papers by Peter D. Cole Breakdown of academic impact, for papers by Gregoris Iconomou Breakdown of academic impact, for papers by Luigi Bergamaschini Breakdown of academic impact, for papers by Caroline Laverdière
Rankless by CCL
2026